IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,855 | -9.9% | 2,521,284 | +4.0% | 0.02% | -5.0% |
| Q2 2023 | $145,309 | +112.4% | 2,423,420 | +75.2% | 0.02% | +100.0% |
| Q1 2023 | $68,398 | -10.2% | 1,383,440 | +3.7% | 0.01% | -16.7% |
| Q4 2022 | $76,127 | -99.9% | 1,333,916 | +14.6% | 0.01% | +33.3% |
| Q3 2022 | $54,618,000 | +366.3% | 1,163,561 | +270.7% | 0.01% | +800.0% |
| Q2 2022 | $11,712,000 | +14.1% | 313,899 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $10,264,000 | -21.1% | 343,279 | -9.6% | 0.00% | 0.0% |
| Q4 2021 | $13,007,000 | -3.1% | 379,891 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $13,420,000 | -6.4% | 362,026 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $14,343,000 | -13.1% | 367,304 | -5.3% | 0.00% | -50.0% |
| Q1 2021 | $16,513,000 | – | 387,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |